![](https://webarchive.library.unt.edu/eot2008/20090201094559im_/http://www.genome.gov/Images/spacer2.gif) |
Recent Articles from the National Human Genome Research Institute
Web Feed | What's This?
An ongoing list of articles and talks from the researchers at the National Human Genome Research Institute (NHGRI).
Archive of Recent Articles: 2002-2008
2009
-
January 29, 2009:
Gene Therapy Fulfilling Its Promise [content.nejm.org]
NHGRI Senior Investigator Fabio Candotti, M.D., of the Genetics and Molecular Biology Branch, and co-author Donald B. Kohn, M.D., Keck School of Medicine, University of Southern California, comment on prospects for continuing advancement of gene therapy for treatment of genetic diseases in light of the outcome of gene therapy for severe combined immunodeficiency disease, or SCID, due to deficiency of the enzyme adenosine deaminase (ADA), reported in recent trials.
- Dr. Canotti's and Dr. Kohn's comments were based on the NEJM article:
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
[Abstract]
Last Updated: January 30, 2008
|
![](https://webarchive.library.unt.edu/eot2008/20090201094559im_/http://www.genome.gov/Images/spacer2.gif) |